Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patient

Author:

Wedd Joel P.1,Nordstrom Eric2,Nydam Trevor3,Durham Janette4,Zimmerman Michael5,Johnson Thor4,Thomas Purcell W.6,Biggins Scott W.2

Affiliation:

1. Division of Digestive Diseases, Department of Medicine; Emory University School of Medicine; Atlanta GA

2. Division of Gastroenterology and Hepatology; University of Colorado; Aurora CO

3. Department of Surgery; University of Colorado; Aurora CO

4. Department of Interventional Radiology; Anschutz Medical Campus, University of Colorado; Aurora CO

5. Department of Surgery; Medical College of Wisconsin; Milwaukee WI

6. Division of Medical Oncology; University of Colorado; Aurora CO

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference83 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States;Altekruse;Am J Gastroenterol,2014

3. Emerging trends in hepatocellular carcinoma incidence and mortality;Njei;Hepatology,2015

4. Hepatocellular carcinoma in cirrhosis: incidence and risk factors;Fattovich;Gastroenterology,2004

5. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver;Yao;Transpl,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3